|
|
|
|
|
CUSIP No. 13781Y103 |
|
13D |
|
Page 9 of 16 pages |
Item 1. |
Security and Issuer. |
This statement on Schedule 13D (the Schedule 13D) relates to the Common Stock, par value $0.0001 per share (Common
Stock), of Cano Health, Inc., a Delaware corporation (the Issuer), whose principal executive offices are located at 9725 NW 117th Avenue, Suite 200, Miami, FL 33178.
Item 2. |
Identity and Background. |
The Schedule 13D is being filed by the following persons (each a Reporting Person and, collectively, the Reporting
Persons):
(1) The Carlyle Group Inc.
(2) Carlyle Holdings I GP Inc.
(3) Carlyle Holdings I GP Sub L.L.C.
(4) Carlyle Holdings I L.P.
(5)
CG Subsidiary Holdings L.L.C.
(6) TC Group, L.L.C.
(7) Carlyle Investment Management L.L.C.
(8) Carlyle CLO Management L.L.C.
Each of the Reporting Persons is organized under the laws of the State of Delaware. The address for each of the Reporting Persons is c/o The
Carlyle Group, 1001 Pennsylvania Ave. NW, Suite 220 South, Washington, DC 20004-2505. Each of the Reporting Persons is principally engaged in the business of investing in securities.
The directors of The Carlyle Group Inc. are Afsaneh Beschloss, Sharda Cherwoo, Daniel A. DAniello, David M. Rubenstein, William E.
Conway, Jr., Linda H. Filler, Lawton W. Fitt, James H. Hance, Jr., Mark S. Ordan, Derica W. Rice, Harvey M. Schwartz, William J. Shaw and Anthony Welters (collectively, the Directors).
The executive officers of The Carlyle Group Inc. are Harvey M. Schwartz, Chief Executive Officer, John Redett, Chief Financial Officer and
Head of Corporate Strategy, Jeffrey W. Ferguson, General Counsel and Lindsay LoBue, Chief Operating Officer (collectively, the Executive Officers, and, together with the Directors, the Related Persons).
Each of the Related Persons is a citizen of the United States. The business address of each of the Related Persons is c/o The Carlyle Group,
1001 Pennsylvania Ave. NW, Suite 220 South, Washington, DC 20004-2505.
The present principal occupation of each of the Directors is as
follows: Harvey M. Schwartz is the Chief Executive Officer of The Carlyle Group; William E. Conway, Jr. is a Co-Founder and Non-Executive
Co-Chairman of The Carlyle Group; Daniel A. DAniello is a Co-Founder and Non-Executive Chairman Emeritus of The Carlyle
Group; David M. Rubenstein is a Co-Founder and Non-Executive Co-Chairman of The Carlyle Group; Afsaneh Beschloss is the Chief
Executive Officer of RockCreek; Sharda Cherwoo is a retired Partner of Ernst & Young; Linda H. Filler is the retired President of Retail Products, Chief Marketing Officer, and Chief Merchandising Officer at Walgreen Co.; Lawton W. Fitt is
an independent investment banking